GlaxoSmithKline's ViiV Healthcare hosted its second live Facebook cabaret, "Meeting the Moment," which featured singers, poets and speakers from the HIV community. ViiV's other educational efforts include production of a second season of its "Be Seen" podcast.
"The Mind Control Menace" created by FCB New York and Marvel Comics, in partnership with the FDA, is a digital and animated comic book series on the dangers of vaping. It is part of the FDA's "The Real Cost" campaign, which began seven years ago to reduce teen smoking and now has added vaping.
Hollywood script writers are gleaning insight from physicians and other health care professionals as they incorporate COVID-19 into their story lines. "People in fact do believe what they see on TV and it's imperative that we provide accurate information," says Neal Baer, a physician who was a writer and producer on shows like "ER" and "Designated Survivor."
Sten Vermund, dean at the Yale University School of Public Health, commenting in a CNBC article about how health care professionals are working with Hollywood on writing scripts that include COVID-19.
Varian and Google Cloud are working together to boost cancer radiation therapy by building an artificial intelligence-based diagnostic platform. "[W]e have committed ourselves to intelligent cancer care, which seeks to automate routine or repetitive tasks in the radiation oncology workflow through the use of smart algorithms, machine learning and AI," said Corey Zankowski, senior VP of Varian's technology and innovation office.
Diagnostic developer Mobidiag Oy will be acquired by Hologic in a deal worth $795 million. "Mobidiag provides an exceptional new growth platform, which will generate long-term value by enabling us to enter the acute care market, which is expected to roughly double in the next five years, with a differentiated, highly competitive solution," said Hologic President and CEO Steve MacMillan.
Researchers from the Indiana University School of Medicine have developed a blood test that can determine if a person has a higher risk of developing bipolar disorder or severe depression. "We wanted to develop blood tests for depression and for bipolar disorder, to distinguish between the two, and to match people to the right treatments," said study leader Alexander Niculescu.
- Page 1